Cargando…
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
BACKGROUND: We examined sponsorship of published cost-effectiveness analyses of statin use for cardiovascular (CV) prevention, and determined whether the funding source is associated with study conclusions. METHODS AND FINDINGS: We searched PubMed/MEDLINE (up to June 2011) to identify cost-effective...
Autores principales: | Catalá-López, Ferrán, Sanfélix-Gimeno, Gabriel, Ridao, Manuel, Peiró, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704635/ https://www.ncbi.nlm.nih.gov/pubmed/23861972 http://dx.doi.org/10.1371/journal.pone.0069462 |
Ejemplares similares
-
Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies
por: Catalá-López, Ferrán, et al.
Publicado: (2012) -
Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis
por: Catalá-López, Ferrán, et al.
Publicado: (2012) -
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
por: Naci, Huseyin, et al.
Publicado: (2014) -
Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis
por: Anglemyer, Andrew T, et al.
Publicado: (2015) -
Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System
por: Librero, Julián, et al.
Publicado: (2012)